|4Feb 25, 3:00 PM ET

Stilley William B. III 4

4 · ADIAL PHARMACEUTICALS, INC. · Filed Feb 25, 2022

Insider Transaction Report

Form 4
Period: 2022-02-23
Stilley William B. III
DirectorChief Executive Officer10% Owner
Transactions
  • Award

    Common Stock

    2022-02-23+250,0001,187,646 total
Footnotes (1)
  • [F1]The restricted shares of Adial Pharmaceuticals, Inc. (the "Company") common stock, par value $0.001 per share (the "Common Stock"), vest as to 166,667 shares monthly on a pro rata basis over 24 months commencing March 23, 2022 and vest as to 83,333 shares on the three year anniversary of the grant date.

Documents

2 files